Update: SCENESSE® in DNA Repair
CLINUVEL PHARMACEUTICALS LTD provided today a clinical update on the use of...
Read More
CLINUVEL News & Facts site live
Earlier this week CLINUVEL launched a new microsite, CLINUVEL News & Facts. The CLINUVEL...
Read More
Media Release - First patient dosed in SCENESSE® DNA Repair Program
Xeroderma pigmentosum (XP) patient receives SCENESSE® treatment In the search for a...
Read More
First patient dosed in SCENESSE® DNA Repair Program
Xeroderma pigmentosum (XP) patient receives SCENESSE® treatment CLINUVEL PHARMACEUTICALS LTD today announced...
Read More
Media Release (ASX) - CLINUVEL progresses innovative DNA Repair Program
Drug tested to protect skin and regenerate DNA, firstly in XP patients...
Read More
Media Release – New drug to repair damaged skin and reduce skin cancer risk
Figure 1: CLINUVEL’s DNA Repair Program aims to confirm that intervention with...
Read More
Media Release – CLINUVEL opens VALLAURIX R&D centre in Singapore
The CLINUVEL Group today announced the opening of its state-of-the-art centralised Research&...
Read More
CLINUVEL Full Year Results 2020
CLINUVEL REPORTS PROFIT, RENVESTING IN BUSINESS Fourth consecutive annual positive net cash...
Read More